Nematode resistant trait coming for Enlist E3 soybeans

Reading Time: < 1 minute

Published: July 28, 2022

,

Roots of a soybean plant infected with nematodes.

Corteva Agriscience, BASF and MS Technologies announced they have entered into a mutually beneficial trait licensing agreement to develop next-generation Enlist E3 soybeans with the nematode resistant soybean (NRS) trait for farmers in the United States and Canada.

As part of this agreement, Corteva and MS Technologies have licensed the Enlist E3 soybean trait to BASF for development with the NRS trait in BASF germplasm. BASF has licensed its NRS trait to Corteva and MS Technologies for use in Enlist E3 soybeans. The three companies anticipate commercialization of Enlist E3 soybean varieties containing the NRS trait in the late 2020s, pending applicable regulatory reviews and completion of field testing.

The new NRS trait is expected to provide unprecedented protection against nematode pests in soybeans, including soybean cyst nematode (SCN). The companies said in a release the NRS trait provides yield protection “above and beyond” the current industry standard native SCN resistance traits, including PI88788 and Peking, as well as protection against some of the most economically important nematode species for soybean farmers beyond North America. including Pratylenchus brachyurus.

Read Also

HJV Equipment assists growers with advanced agricultural technology solutions at its locations in Alliston, Exeter, and Norwich, Ont., Charlottetown, P.E.I., and Grand Falls, N.B. Photo: HJV Equipment

HJV Equipment expands as full-line PTx Trimble dealer

HJV Equipment expands as a full-line PTx Trimble dealer, increasing its capacity to assist growers with advanced agricultural technology solutions.

The Enlist weed control system is an industry-leading system for soybeans, corn and cotton. Enlist E3 soybeans are tolerant to 2,4-D choline, glyphosate and glufosinate herbicides. 

The Enlist E3 soybean trait is jointly developed and owned by Corteva and MS Technologies and was commercialized in 2019.

Terms of the agreement were not disclosed.

explore

Stories from our other publications